Food Allergy Fund

Directions Website Contact the organization

Food Allergy Fund We fund research focused on the underlying causes of food allergies and improved treatments for millions of Americans living with food allergies.

What if a smartwatch could help detect an allergic reaction before symptoms appear?New research is offering promising cl...
10/15/2026

What if a smartwatch could help detect an allergic reaction before symptoms appear?

New research is offering promising clues.

In a study of 104 children undergoing oral food challenges, researchers in Israel, with technology and data analysis support from Anjo.ai found measurable differences in heart rate variability between children who experienced allergic reactions and those who did not.

And the research continues. At Mount Sinai Health System FAF-funded researchers are working with Anjo.ai to take the science further. In preliminary findings shared at FAF's Summit, smartwatch technology detected a child's anaphylactic reaction in real time, before symptoms became clinically apparent.

The goal? Safer food challenges and, ultimately, earlier warnings for families managing food allergies at home.

The collaboration grew out of a connection made through an FAF Summit, reflecting why we bring scientists, innovators and investors together and invest in promising research.

As this research continues, Anjo.ai has also opened preorders for AnjoConnect™, a smartwatch-based product designed to help families stay connected and monitor general wellness. AnjoConnect™ does not detect allergic reactions. That technology is being developed separately through AnjoProtect™.

There's still important work ahead, but the possibilities are exciting.

Swipe to explore the science and what it could mean for families.

What if we could prevent and treat food allergies in entirely new ways?Scientists are exploring new approaches, from eng...
10/13/2026

What if we could prevent and treat food allergies in entirely new ways?

Scientists are exploring new approaches, from engineering gut bacteria to promote immune tolerance to investigating precision nutrition and ways to reprogram immune cells.

The Food Allergy Fund is funding this research to better understand the biology of food allergies and open new paths toward prevention, treatment, and ultimately, a cure.

These approaches are still in the early stages, but they reflect how scientists are thinking differently about what's possible for people living with food allergies.

On October 21, researchers advancing this work will share more at FAF's Innovation Forum.

Swipe to explore the science and meet the researchers.

Today is DAF Day! Donor-advised funds hold charitable dollars that have already been set aside for giving. DAF Day is a ...
10/08/2026

Today is DAF Day!

Donor-advised funds hold charitable dollars that have already been set aside for giving. DAF Day is a reminder to put those dollars to work.

A grant from your DAF to the Food Allergy Fund can help unlock the next food allergy breakthrough to prevent, treat, and ultimately cure, food allergies.

If you have a donor-advised fund, consider recommending a grant to FAF today.

Learn more: https://foodallergyfund.org/give

There’s a lot happening in food allergy right now that would have been hard to imagine even a few years ago.New approach...
10/07/2026

There’s a lot happening in food allergy right now that would have been hard to imagine even a few years ago.

New approaches to prevention, diagnosis and treatment are emerging from the science. Some are already being tested in people. And larger pharmaceutical companies and investors are paying attention.

In two weeks, the Food Allergy Fund Innovation Forum will bring together scientists, biotech leaders, investors and patients in San Francisco to talk about where the field is headed and what it will take to move promising science forward.

👉 Swipe to meet the scientists, biotech leaders and investors taking the stage.

Oct. 21 | 4–6:30 p.m.
The Commonwealth Club

Register at the link in bio.

Food allergy IgE dropped. So why did children still react?A new retrospective study found that food-specific IgE dropped...
10/02/2026

Food allergy IgE dropped. So why did children still react?

A new retrospective study found that food-specific IgE dropped substantially in children taking dupilumab (Dupixent). But reactions occurred during oral food challenges, including anaphylaxis.

It’s one of several new studies we’re following this month.

Also in the October Research Digest: A Phase 3 trial testing remibrutinib for peanut, milk and egg allergies; what the placenta may reveal about persistent food allergy; whether eating more egg and peanut during pregnancy and breastfeeding could prevent allergy; how nerves may “remember” allergens; an unexpected lead on alpha-gal syndrome; and new FAF-funded research on starting peanut OIT early.

Which of these studies do you want to know more about?

Know a food allergy family who would want to see this? Send it their way.

Read the full Research Digest at the link in bio.

Food allergy parenting comes with questions that don't always have easy answers. But they're easier to face together.Sha...
09/30/2026

Food allergy parenting comes with questions that don't always have easy answers. But they're easier to face together.

Share this with a food allergy parent who gets it. ❤️

On Thursday, October 8, join NYC food allergy families for breakfast and a conversation with psychotherapist Elizabeth Baron, LMHC | Maternal Mental Health and FAF CEO Ilana Golant about the emotional side of food allergies, plus the latest research and plenty of time for your questions.

📍 Upper East Side, NYC | 9:00 a.m.
RSVP at the link in bio.

Where else can you ask a biotech CEO, a leading scientist and a top investor what's next for food allergy, all in one ev...
09/29/2026

Where else can you ask a biotech CEO, a leading scientist and a top investor what's next for food allergy, all in one evening?

Meet the game changers: scientists uncovering how the gut microbiome and immune system shape food allergy, biotech leaders testing new approaches to prevention and treatment in clinical trials, and investors who help decide which ideas get the funding to reach patients.

On October 21, they'll all be in one room in San Francisco for an evening of conversation, followed by a networking reception.

📍 The Commonwealth Club, San Francisco
🗓 October 21 | 4–6:30 p.m.

If you're in the Bay Area, we'd love to see you there. Register at the link in bio. Patients and families save 25% with code SFFAMILY.

Would you recognize anaphylaxis in a baby?Infants and toddlers cannot describe an itchy throat or changes in their breat...
09/23/2026

Would you recognize anaphylaxis in a baby?

Infants and toddlers cannot describe an itchy throat or changes in their breathing. Research shows that reactions may include less-obvious signs such as drooling, back arching, belly breathing and tongue thrusting.

These signs can have many causes and do not confirm anaphylaxis on their own.

The research also found an association between having a written action plan and greater epinephrine use during probable anaphylaxis.

Swipe to learn more, then save and share with everyone who cares for your child.

Thanks to Dr. Jay Lieberman, Dr. Stephanie Leeds, Dr. Michael Pistiner and their colleagues for this important research, and to Asthma and Allergy Foundation whose Infant Toddler Anaphylaxis Study contributed data to this body of work.

San Francisco, we’re one month away!On October 21, hear directly from scientists exploring:• How the immune system recog...
09/21/2026

San Francisco, we’re one month away!

On October 21, hear directly from scientists exploring:

• How the immune system recognizes food proteins
• How gut bacteria may influence allergy severity
• Whether engineered beneficial bacteria could become a treatment

Biotech leaders will also discuss potential treatments now being studied in clinical trials, what they are learning and what comes next.

October 21 | 4–6:30 p.m.
The Commonwealth Club | San Francisco

Patients and families save 25% with code SFFAMILY.

Register through the link in our bio.

A needle-free film placed under the tongue to treat anaphylaxis? Here’s the latest.The U.S. FDA previously declined to a...
09/18/2026

A needle-free film placed under the tongue to treat anaphylaxis? Here’s the latest.

The U.S. FDA previously declined to approve Anaphylm, requesting additional testing of its packaging, how people administer it and how the medicine is absorbed. Aquestive Therapeutics has now resubmitted its application with revised packaging and instructions and new study results.

In company-reported results, median pouch-opening time decreased from 17 seconds in an earlier study to 3 seconds in the new study. Median time to open and administer the first dose decreased from 46 seconds to 17 seconds.

Those numbers measure handling time, not how quickly the medicine works.

Anaphylm is not yet FDA-approved. If approved, it would offer another needle-free option for treating anaphylaxis.

Swipe to learn about the film, the new findings and what happens next. Share this update with someone living with food allergies.

Sources: Aquestive Therapeutics’ August 2026 study results and September 17, 2026 announcement.

Address

New York, NY

Alerts

Be the first to know and let us send you an email when Food Allergy Fund posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Food Allergy Fund:

Shortcuts

Share